115 related articles for article (PubMed ID: 8809956)
41. Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.
Peerschke EI; Moung C; Pessin MS; Maslak P
Transfusion; 2015 Aug; 55(8):2001-9. PubMed ID: 25808236
[TBL] [Abstract][Full Text] [Related]
42. Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF.
Mitterer M; Hirber J; Gentilini I; Prinoth O; Fabris P; Emmerich B; Coser P; Straka C
Bone Marrow Transplant; 1996 Sep; 18(3):611-7. PubMed ID: 8879626
[TBL] [Abstract][Full Text] [Related]
43. Associations among white blood cells, CD34+ cells and GM-CFU in predicting the optimal timing of peripheral blood stem cell collections by apheresis.
Boulassel MR
J Assoc Physicians India; 2008 Feb; 56():96-8. PubMed ID: 18472508
[TBL] [Abstract][Full Text] [Related]
44. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
Kelly M; Roy DC; Labbe AC; Laverdiere M
Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
[TBL] [Abstract][Full Text] [Related]
45. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
[TBL] [Abstract][Full Text] [Related]
46. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
[TBL] [Abstract][Full Text] [Related]
47. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.
Bühler L; Kurilla-Mahon B; Chang Q; Abraham S; Alwayn IP; Appel JZ; Newman D; Awwad M; White-Scharf ME; Sackstein R; Sachs DH; Cooper DK; Down JD
Transplantation; 2002 Oct; 74(8):1159-66. PubMed ID: 12438964
[TBL] [Abstract][Full Text] [Related]
48. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.
Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB
Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956
[TBL] [Abstract][Full Text] [Related]
49. Microbiologic contamination of peripheral blood stem cell autografts.
Schwella N; Zimmermann R; Heuft HG; Blasczyk R; Beyer J; Rick O; Kreissig C; Zingsem J; Eckstein R; Siegert W
Vox Sang; 1994; 67(1):32-5. PubMed ID: 7975449
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
51. A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.
Cornelissen JJ; van der Holt B; Petersen EJ; Vindelov L; Russel CA; Höglund M; Maertens J; Schouten HC; Braakman E; Steijaert MM; Zijlmans MJ; Slaper-Cortenbach I; Boogaerts MA; Löwenberg B; Verdonck LF
Exp Hematol; 2003 Oct; 31(10):855-64. PubMed ID: 14550800
[TBL] [Abstract][Full Text] [Related]
52. Cryopreservation reduces the concentration of detectable bacteria in contaminated peripheral blood progenitor cell products.
Kipp F; Linnemann E; Fischer RJ; Sibrowski W; Cassens U
Transfusion; 2004 Jul; 44(7):1098-103. PubMed ID: 15225253
[TBL] [Abstract][Full Text] [Related]
53. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
54. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review.
Nasser RM; Hajjar I; Sandhaus LM; Hall GS; Avery RK; Bolwell BJ; Longworth DL; Adal KA
Clin Infect Dis; 1998 Oct; 27(4):886-8. PubMed ID: 9798046
[TBL] [Abstract][Full Text] [Related]
55. Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution.
Mele L; Dallavalle FM; Verri MG; Balza G; Allione B; Salvi F; Levis A; Caraccio V; Borzini P
Transfus Apher Sci; 2005 Nov; 33(3):269-74. PubMed ID: 16239124
[TBL] [Abstract][Full Text] [Related]
56. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
[TBL] [Abstract][Full Text] [Related]
57. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
58. Peripheral blood progenitor cell collection during hematopoietic recovery following autologous blood progenitor cell transplantation.
Schwella N; Kingreen D; Heuft HG; Oettle H; Rick O; Serke S; Huhn D; Siegert W
Vox Sang; 1997; 72(2):118-20. PubMed ID: 9088081
[TBL] [Abstract][Full Text] [Related]
59. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
60. Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?
Akkök CA; Liseth K; Melve GK; Ersvaer E; Hervig T; Bruserud Ø
Cytotherapy; 2011 Sep; 13(8):1013-24. PubMed ID: 21504376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
